PACeS

This study is to compare two treatments for atrial fibrillation or atrial flutter (both referred to as AF) after cardiac surgery. AF is the most common irregular heartbeat after surgery and is associated with increased risk of stroke, heart failure and hospitalization. Patients who have this heartbeat are also at higher risk of developing blood clots. This study is to determine which of two standard hospital treatments is safer for patients after Coronary Artery Bypass Graft surgery. Antiplatelet or anticoagulants. Antiplatelet drugs (like aspirin) prevent clots from forming by stopping platelets (blood cell fragments) from clumping together where anticoagulants (like warfarin or apixaban) "thin" blood so it is less likely to clot.

null

Étude parrainée par

University of Alberta

Participants recherchés

Plus d'informations

ID de l'étude: Pro00098055